ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 3391 - 3405 of 5738 products
Eisai In-Licenses China Rights for Two Parkinson's Drugs from Orion
$5.00
Available
Hong Kong's Ally Bridge Invests in Two European Biopharmas
$5.00
Available
BioSense Inks $68 Million Deal for Neovacs
$5.00
Available
Lee's Pharm to Market Solasia's Oral Mucositis Treatment in China
$5.00
Available
Hutchison MediTech Begins Phase II Study of Its PSC Drug Savolitinib in China
$5.00
Available
Genecast of Beijing Raises $18 Million for Cancer DNA Diagnostics
$5.00
Available
Aslan Pharma Reports Positive Data for HER-2 Cancer Drug
$5.00
Available
Shanghai's Abbisko Therapeutics Raises $28 Million for Cancer Drugs
$5.00
Available
Shanghai's Ark Biosciences Closes A+ Funding for Anti-Virals
$5.00
Available
Sirnaomics, a US-China Biopharma, Starts Trial of RNAi Candidate
$5.00
Available
WuXi AppTec's STA Pharma to Expand Changzhou Site
$5.00
Available
Vexim Starts China Development of Vertebra Fracture Repair Device
$5.00
Available
China to Announce New National Drug Reimbursement List
$0.00
Available
Vincent Medical Strikes $3 Million Medical Device Deal with Israel's Inovyte
$5.00
Available
FibroGen's Novel Anemia Treatment Meets Phase III Endpoints in China
$5.00
Available